Group 1 - The core point of the article is that Zai Lab (688266) has announced an international patent application for a new compound, indicating ongoing innovation in its drug development pipeline [1] - The patent is titled "Halogenated Alkyl Substituted Cycloalkyl or Heterocyclic Inhibitors and Their Preparation Methods and Applications," with the application number PCT/CN2025/110184 and an international publication date set for January 29, 2026 [1] - In 2025, Zai Lab has filed one international patent application so far, reflecting its commitment to research and development [3] Group 2 - In the first half of 2025, Zai Lab invested 197 million yuan in research and development, which represents an 8.47% year-on-year increase [3]